For many years in Australia, we’ve talked about the future of personalised medicines and disruptive innovation. We are now at a stage where advances predicted in previous years are here.

At the same time, we are recognising changes in our approach to health outcomes, from focusing on population health outcomes, to a new present where individual factors are better understood.

At this event, we will present discussions and scenarios from Australia and around the world to demonstrate the impacts and opportunities of this current future. We will contextualise real world examples of the impact that personalised medicine and other disruptive innovations are having now, and how they are influencing health decision-making at all levels.


Plenary overview

Evolving systems
Evolving systems examines where the gaps and opportunities are, and how systems are evolving and adapting.

Reimagining policies
Reimagining policies asks how the regulatory and policy environment is responding to changes in treatments and healthcare.

Clinical innovations
Clinical innovations explores what is emerging in clinical care and treatments to drive better patient outcomes.


Wednesday 30 May

Time Session
9.45 Choosing Wisely National Meeting
4.00 Welcome reception and registration for NMS 2018
Foyer, National Convention Centre Canberra

Thursday 31 May

Time Session Speakers
7.30 Registration
Foyer, National Convention Centre Canberra, ground floor
Session A: Prepare to be inspired and immersed in the symposium themes – how systems are evolving, the reimagining of policies and clinical innovation. Explore opportunities, challenges and the world of change here and on the horizon.
8.30 Official opening of NMS 2018 Virginia Haussegger AM
Conference MC
  Welcome to country  Wally Bell, on behalf of the Ngunnawal people
  Opening address Dr Lynn Weekes AM
Chief Executive Officer, NPS MedicineWise
9.00 Keynote address:
Reshaping healthcare and harnessing the potential - 100
Professor Keith McNeil
Queensland Health
9.45 Panel discussion
Perspectives from the coalface – shifting from population to personal healthcare

Facilitated by Virginia Haussegger AM 

Leanne Wells
Consumers Health Forum

Dr Matthew Anstey
Sir Charles Gairdner Hospital

Professor Michael Dooley
Alfred Health

Foyer, ground floor
Concurrent sessions 1: Experience an exciting showcase of work from across Australia and beyond. Gain insights into cutting edge research, novel problem-solving, improving utilisation and decision making, and ways the sector navigates this fact-changing landscape. Includes a dedicate stream on innovative solutions to the global challenge of antimicrobial resistance.

Concurrent sessions  1
1.1 Pitch presentationsFitzroy room
1.2 Lightning talks - Evolving systems and reimagining policiesTorrens room
1.3 Panel discussionDerwent room
1.4 Digital data streamSwan room
1.5 Antimicrobial resistance (AMR) streamMurray room

11.45 Concurrent sessions 1 (cont.)
12.30 LUNCH
Evolving systems poster session (12:45–13:15)
Foyer, ground floor

DVA workshopVeterans’ MATES: engaging veterans and health professionals to improve health outcomes for veterans - 120 (12:45–13:15)
Dr Anna Moffat, Evaluation Leader, Veterans’ MATES, Natalie Blacker, Development Coordinator, Veterans’ MATES, Dr Lisa Kalisch Ellett, Senior Research Fellow, Veterans’ MATES

Murray room

Session B: Take a deep dive into the subtheme of reimagining policies. There are lots of questions, but nowhere near as many answers. How are regulators and policy makers responding to new and emerging health technologies, and balancing safety, timely access. and cost effectiveness with stakeholder and community expectations? This is sure to be a challenging and insightful conversation.
1.30 Keynote address
Adaptive regulatory pathways - 1style="color: red;"21
Dr Hans-Georg Eichler
European Medicines Agency 
2.10 Panel discussion
Australian perspective on innovations in policy making and health technology assessment
Facilitated by Virginia Haussegger AM 
Adjunct Professor John Skerritt
Health Products Regulation, Department of Health

Professor Andrew Wilson
Pharmaceutical Benefits Advisory Committee

Jo Watson
Consumers Health Forum

Penny Shakespeare
Department of Health
Foyer, ground floor
Session C: New and emerging health technologies offer more healthcare options than at any other time in our history. This session explores the importance of clinical and cultural competence, and examines clinical innovations changing practice and health care decision making.
3.30 Keynote address
Clinical and cultural competence in a fast-changing world - 122
Professor Lisa Jackson Pulver
Western Sydney University
3.55 Keynote address
Genomic medicine: preparing Australia for this disruptive technology - 123
Professor John Christodoulou
Australian Genomics Health Alliance
4.20 Keynote address
Genomics, personalised medicines and the dangers of overdiagnosis - 124
Dr Ray Moynihan
Bond University
4.45 Speaker question and answers

Facilitated by Virginia Haussegger AM 
Lisa Jackson Pulver
John Christodoulou
Ray Moynihan
5.00 Recap from consumer rapporteurs   Melissa Cadzow and Debra Letica
5.15 CLOSE OF DAY 1  
7.00 Symposium Dinner and National Medicinewise Awards
National Arboretum Canberra, Forest Drive off Tuggeranong Parkway, Weston Creek, ACT
Return coach transfers depart from the National Convention Centre at 18:45 and return from 22:30 

Friday 1 June

Time Session Speakers
7.30 Registration
Foyer, National Convention Centre Canberra
Session D: Unmissable opportunity to hear from national and international experts about innovations in the world of genomics and personalised medicine. Learn how medicine and health care is changing, what these changes mean for clinicians and consumers, and implications for sound health care decision making at all levels.
8.30 Opening of day two  
8.40 Keynote address
Systems medicine approaches to the challenges of 21st century personalised and public healthcare - 200
Professor Jeremy Nicholson
Imperial College London
9.30 Keynote address
Convergence of engineering, IT and clinical practice: opportunities and challenges - 201
Professor Iven Mareels
IBM Research
9.55 Keynote address
Law, ethics and practice … bringing consumers on the personalised medicine journey - 202
Dr Harriet Teare
Centre for Health Law and Emerging Technologies Oxford, UK

Speaker questions and answers

Facilitated by Virginia Haussegger AM 

Foyer, ground floor
Concurrent sessions 2: An exciting showcase of work from across Australia and beyond. Gain insights into cutting edge research, novel problem-solving, improving utilisation and decision making, and ways the sector navigates this fast-changing landscape. Includes a dedicated stream exploring new and emerging approaches to addressing the global challenge of antimicrobial resistance.
11.00 Concurrent sessions 2
2.1 Pitch presentationsFitzroy room
2.2 Lightning talks - Clinical innovationTorrens room
2.3 Panel discussionDerwent room
2.4 Digital data streamSwan room
2.5 Antimicrobial resistance (AMR) streamMurray room
11.45 Concurrent sessions 2 (cont.)
12.30 LUNCH 
Clinical innovations poster session
Reimagining policies poster session (12:45–13:15)
Foyer, ground floor
Session E: What difference does personal health care make in people’s lives? Gain unique insights from the lived experience of people in this thought-provoking and inspiring session. The final panel discussion will draw together insights, solutions and ideas and provide delegates with key take-outs and learnings.
1.30 Keynote address
Misdiagnosed, misunderstood, missing out: the journey for many -226
Susan Morris
Lynch Syndrome Australia
2.15 Panel discussion
The future is now… how do we make sure we’re ready?

Facilitated by Virginia Haussegger AM
Professor Jeremy Nicholson
Professor Hans-Georg Eichler
Susan Morris
Dr Lynn Weekes
Dr Harriet Teare
Consumer rapporteurs
3.15 Wrap-up and close of NMS 2018  
3.30 CLOSE OF DAY 2  


Date published : 15 May 2018